Type 1 diabetes reduced substance P and CGRP neuropeptide levels in the jaw joint, causing numbness to pain while inflammation continued to silently damage tissues.
Day 7 onsetC-fiber nociceptors in the jaw joint became hyporesponsive just one week after diabetes induction, with reduced substance P and CGRP levels
What the researchers found
In streptozotocin-induced type 1 diabetic rats, C-fiber nociceptors in the temporomandibular joint became hyporesponsive starting from day 7 after disease induction. This was associated with significantly reduced protein levels of the neuropeptides substance P and calcitonin gene-related peptide (CGRP).
Paradoxically, while pain sensing decreased, inflammatory markers increased — higher levels of pro-inflammatory cytokine IL-1β and chemokine CINC-1/CXCL-1 were observed. PKC-α/β inhibitor (GO6976) or PKC-β inhibitor (LY333531) treatment restored capsaicin-induced nociception and increased Na+/K+-ATPase pump levels in the trigeminal ganglia.
The overall picture suggests diabetes creates a condition where tissue-damaging inflammation proceeds without pain perception, potentially leading to undetected joint degeneration.
Why it matters
Diabetic patients frequently develop neuropathy where they lose pain sensation while tissue damage continues unchecked — this is why diabetic foot ulcers become so severe. This study shows the same dangerous pattern occurs in the jaw joint, driven by neuropeptide depletion, and identifies PKC signaling as a potential target to restore protective pain sensing.
How the study worked
Wistar rats received streptozotocin (75 mg/kg) to induce type 1 diabetes. TMJ nociception was assessed using capsaicin and formalin challenges. Neuropeptide levels (substance P, CGRP), inflammatory markers (IL-1β, CINC-1/CXCL-1), and Na+/K+-ATPase pump protein levels were measured in the trigeminal ganglia. PKC inhibitors were used to investigate the signaling mechanism underlying nociceptor hyporesponsiveness.
What this study cannot tell us
This is an animal study using streptozotocin-induced diabetes, which models type 1 diabetes and may not fully represent the slower-onset type 2 diabetes. The TMJ findings may not translate directly to other joints. Only early-phase diabetes was studied; long-term effects were not examined. The specific mechanisms linking diabetes to neuropeptide reduction need further investigation.
How to read the evidence
This is a preclinical animal study using a standard diabetes model. The mechanistic data combining nociception testing, neuropeptide measurement, and pharmacological intervention is thorough, but results require validation in human subjects.
When this study was published
Published in 2019, this study provides insight into the early mechanisms of diabetic neuropathy in the orofacial region, a relatively understudied area of diabetic complications.
The bigger picture
This study adds to the understanding of diabetic neuropathy by showing that neuropeptide depletion isn't just about losing sensation — it also removes the body's early warning system for tissue damage. The finding that PKC inhibitors can restore pain sensitivity suggests potential therapeutic approaches to prevent the silent tissue destruction that characterizes diabetic complications.
Questions still open
- Do diabetic patients with TMJ disorders present later because they don't feel early pain?
- Could PKC inhibitors prevent silent joint degeneration in diabetic patients?
- Is this neuropeptide depletion pattern reversible with good blood sugar control?
Common questions
What are substance P and CGRP, and why do they matter for pain?
Could this explain why diabetic patients have worse dental and jaw problems?
Read the original research
Early Phase of Type 1 Diabetes Decreases the Responsiveness of C-Fiber Nociceptors in the Temporomandibular Joint of Rats.
Neuroscience, 416, 229-238
Citation
Rocha-Neto, Luiz M; Gamarra-Suárez, Jaime R; Freitas, Fabiana F; Muzilli, Augusto; Abdalla, Henrique B; Macedo, Cristina G; Napimoga, Marcelo H; Clemente-Napimoga, Juliana T. (2019). Early Phase of Type 1 Diabetes Decreases the Responsiveness of C-Fiber Nociceptors in the Temporomandibular Joint of Rats.. Neuroscience, 416, 229-238. https://doi.org/10.1016/j.neuroscience.2019.08.011